{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:47:19Z","timestamp":1776926839433,"version":"3.51.2"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"QIAGEN"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>\n            Interferon gamma release assays (IGRAs) are important tools in identifying prior tuberculosis exposure. The new-generation QuantiFERON-TB Gold Plus (QFT-Plus) assay, recently approved for use in the United States, differs from the current-generation QFT Gold-In-Tube (QFT-GIT) assay with the addition of a second antigen tube that also contains novel CD8\n            <jats:sup>+<\/jats:sup>\n            T-cell-stimulating peptides.\n          <\/jats:p>","DOI":"10.1128\/jcm.00629-18","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T01:50:31Z","timestamp":1537494631000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay"],"prefix":"10.1128","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-2632","authenticated-orcid":false,"given":"S. A. R.","family":"Siegel","sequence":"first","affiliation":[{"name":"School of Public Health, Oregon Health &amp; Science University-Portland State University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cavanaugh","sequence":"additional","affiliation":[{"name":"Oregon State Public Health Laboratory, Hillsboro, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Ku","sequence":"additional","affiliation":[{"name":"School of Public Health, Oregon Health &amp; Science University-Portland State University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Qiagen, Germantown, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. L.","family":"Winthrop","sequence":"additional","affiliation":[{"name":"School of Public Health, Oregon Health &amp; Science University-Portland State University, Portland, Oregon, USA"},{"name":"Division of Infectious Diseases, Oregon Health &amp; Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw376"},{"key":"e_1_3_2_3_2","volume-title":"QuantiFERON TB Gold (QFT) ELISA package insert","author":"Qiagen","year":"2013","unstructured":"Qiagen. 2013. QuantiFERON TB Gold (QFT) ELISA package insert. Qiagen, Hilden, Germany. http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/2PK\/UK.pdf. Accessed 7 October 2016."},{"key":"e_1_3_2_4_2","volume-title":"QuantiFERON-TB Gold Plus ELISA package insert","author":"Qiagen","year":"2015","unstructured":"Qiagen. 2015. QuantiFERON-TB Gold Plus ELISA package insert. Qiagen, Hilden, Germany http:\/\/www.quantiferon.com\/irm\/content\/package-inserts.aspx. Accessed 7 October 2016."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.270"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.439"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030127"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02033-2015"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101122"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243262"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.11.023"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.06.009"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(13)70012-X"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201107-1355OC"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02742-2"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093986"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/345760"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/376628"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177752"},{"issue":"6","key":"e_1_3_2_21_2","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"American Thoracic Society","year":"2000","unstructured":"American Thoracic Society. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recommend Rep 49(RR-6):1\u201351.","journal-title":"MMWR Recommend Rep"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02498-16"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0320-3"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201412-559OC"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201002-0310OC"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw694"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201979"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200408"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00683-09"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.5.1274-1282.1996"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)90051-1"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00629-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00629-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:12:08Z","timestamp":1646475128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00629-18"}},"subtitle":[],"editor":[{"given":"Betty A.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1128\/JCM.00629-18"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00629-18","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2018-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00629-18"}}